Spots Global Cancer Trial Database for Longterm Observational Study in Subjects Treated With AA4500 in AUX-CC-854, 856, 857, 858 & 859
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Longterm Observational Study in Subjects Treated With AA4500 in AUX-CC-854, 856, 857, 858 & 859
Official Title: CORDLESS- Collagenase Optimal Reduction of Dupuytren's - Long-term Evaluation of Success Study
Study ID: NCT00954746
Conditions
Interventions
Study Description
Brief Summary: The purpose of study AUX-CC-860 is to assess the durability of response of the AA4500 treatment regimen. This study will also evaluate long-term safety and progression of disease in joints.
Detailed Description: Phase 3 non-treatment study in which Year 2 to Year 5 year follow-up of subjects who received AA4500 in the 9-month open-label studies (AUX-CC-854 and AUX-CC-856) or the 12-month double-blind with open-label extension studies (AUX-CC-857/AUX-CC-858 and AUX-CC-859). After completion of one of the above mentioned studies, subjects are enrolled and followed once a calendar year for 4 consecutive years with at least 6 months between consecutive visits.
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Hope Research Institute, Phoenix, Arizona, United States
Tucson Orthopedic Institute, P.C., Tucson, Arizona, United States
Providence Clinical Research, Burbank, California, United States
100 UCLA Medical Plaza, Suite 305, Los Angeles, California, United States
Hand Surgery Clinic, Palo Alto, California, United States
The Hand and Upper Extremity Center of Georgia, P.C., Atlanta, Georgia, United States
Southern Illinois Hand Center, S.C., Effingham, Illinois, United States
Rockford Orthopedic Associates, Ltd., Rockford, Illinois, United States
The Indiana Hand Center, Indianapolis, Indiana, United States
Via Christi Research, Wichita, Kansas, United States
Brigham and Women's Hospital, Department of Orthopedic Surgery, Boston, Massachusetts, United States
Newton-Wellesley Hospital, Newton, Massachusetts, United States
Marquette General Health System, Marquette, Michigan, United States
TRIA Orthopaedic Center, Minneapolis, Minnesota, United States
Hospital for Special Surgery, New York, New York, United States
SUNY Stony Brook - Department of Orthopedics, Stony Brook, New York, United States
The Bone and Joint Center, Bismark, North Dakota, United States
Health Research Institute, Oklahoma city, Oklahoma, United States
Hand Microsurgery & Reconstructive Orthopedics, Erie, Pennsylvania, United States
University Orthopedics Center, State College, Pennsylvania, United States
University Orthopedics, Inc., Providence, Rhode Island, United States
Alpha Clinical Research, Clarksville, Tennessee, United States
Accurate Clincal Research, Houston, Texas, United States
Royal North Shore Hospital, St Leonards, New South Wales, Australia
Rivercity Hospital, Auchenflower, Queensland, Australia
Caboolture Clinical Research Centre, Caboolture, Queensland, Australia
Peninsula Clinical Research, Kippa Ring, Queensland, Australia
Menzies Research Institute, Hobart, Tasmania, Australia
Emeritus Research, Malvern, Victoria, Australia
Gentofte Hospital, Hellerup, Copenhagen, Denmark
Hospital of Aalborg, Aalborg, , Denmark
Rigshospitalet, Copenhagen, , Denmark
Dextra, Helsinki, , Finland
Koskiklinikka, Tampere, , Finland
Department of Hand Surgery, Malmo, , Sweden
Department of Hand Surgery, Akademiska University Hospital, Uppsala, , Sweden
Pulvertaft Hand Clinic, Derby, Derbyshire, United Kingdom
Newcastle Biomedicine Clinical Research Facility, Newcastle, Newcastle Upon Tyne, United Kingdom
Welsh Centre for Plastic Surgery Morriston Hospital, Swansea, Wales, United Kingdom
Contact Details
Name: Veronica Urdaneta, MD
Affiliation: Endo Health Solutions
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
